Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 93

    1.

    A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.

    Gandhi RT, O'Neill D, Bosch RJ, Chan ES, Bucy RP, Shopis J, Baglyos L, Adams E, Fox L, Purdue L, Marshak A, Flynn T, Masih R, Schock B, Mildvan D, Schlesinger SJ, Marovich MA, Bhardwaj N, Jacobson JM; AIDS Clinical Trials Group A5130 team.

    Vaccine. 2009 Oct 9;27(43):6088-94. Epub 2009 May 29.PMID: 19450647 [PubMed - indexed for MEDLINE]Related articles

    2.

    Preferential priming of alloreactive T cells with indirect reactivity.

    Brennan TV, Jaigirdar A, Hoang V, Hayden T, Liu FC, Zaid H, Chang CK, Bucy RP, Tang Q, Kang SM.

    Am J Transplant. 2009 Apr;9(4):709-18.PMID: 19344462 [PubMed - indexed for MEDLINE]Related articles

    3.

    Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

    Tsang JY, Tanriver Y, Jiang S, Xue SA, Ratnasothy K, Chen D, Stauss HJ, Bucy RP, Lombardi G, Lechler R.

    J Clin Invest. 2008 Nov;118(11):3619-28. Epub 2008 Oct 9.PMID: 18846251 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    CD8+ suppressor T cells resurrected.

    Kapp JA, Bucy RP.

    Hum Immunol. 2008 Nov;69(11):715-20. Epub 2008 Sep 24. Review.PMID: 18817830 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline.

    Kilby JM, Lee HY, Hazelwood JD, Bansal A, Bucy RP, Saag MS, Shaw GM, Acosta EP, Johnson VA, Perelson AS, Goepfert PA; UAB Acute Infection, Early Disease Research Program (AIEDRP) Group.

    AIDS. 2008 May 11;22(8):957-62.PMID: 18453855 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects.

    Twigg Iii HL, Weiden M, Valentine F, Schnizlein-Bick CT, Bassett R, Zheng L, Wheat J, Day RB, Rominger H, Collman RG, Fox L, Brizz B, Dragavon J, Coombs RW, Bucy RP; AIDS Clinical Trials Group Protocol 723 Team.

    J Infect Dis. 2008 Jan 1;197(1):109-16.PMID: 18171293 [PubMed - indexed for MEDLINE]Related articles

    7.

    Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.

    Kapp JA, Honjo K, Kapp LM, Goldsmith K, Bucy RP.

    J Immunol. 2007 Aug 15;179(4):2105-14.PMID: 17675469 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

    Mitsuyasu R, Gelman R, Cherng DW, Landay A, Fahey J, Reichman R, Erice A, Bucy RP, Kilby JM, Lederman MM, Hamilton CD, Lertora J, White BL, Tebas P, Duliege AM, Pollard RB; AIDS Clinical Trials Group 328 Study Team.

    Arch Intern Med. 2007 Mar 26;167(6):597-605.PMID: 17389292 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).

    Kilby JM, Bucy RP, Mildvan D, Fischl M, Santana-Bagur J, Lennox J, Pilcher C, Zolopa A, Lawrence J, Pollard RB, Habib RE, Sahner D, Fox L, Aga E, Bosch RJ, Mitsuyasu R; Adult AIDS Clinical Trials Group A5024 Protocol Team.

    J Infect Dis. 2006 Dec 15;194(12):1672-6. Epub 2006 Nov 8.PMID: 17109338 [PubMed - indexed for MEDLINE]Related articles

    10.

    TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection.

    Kapp JA, Honjo K, Kapp LM, Xu X, Cozier A, Bucy RP.

    Int Immunol. 2006 Nov;18(11):1549-62. Epub 2006 Sep 11.PMID: 16966495 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Viral and cellular dynamics in HIV disease.

    Bucy RP.

    Curr HIV/AIDS Rep. 2004 Apr;1(1):40-6. Review.PMID: 16091222 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intratumoral administration of a recombinant canarypox virus expressing interleukin 12 in patients with metastatic melanoma.

    Triozzi PL, Strong TV, Bucy RP, Allen KO, Carlisle RR, Moore SE, Lobuglio AF, Conry RM.

    Hum Gene Ther. 2005 Jan;16(1):91-100.PMID: 15703492 [PubMed - indexed for MEDLINE]Related articles

    14.

    Activation and migration of allo-peptide specific TCR transgenic T cells in cardiac allograft rejection.

    Honjo K, Xu XY, Kapp JA, Bucy RP.

    Cell Immunol. 2004 Jul;230(1):44-55.PMID: 15541718 [PubMed - indexed for MEDLINE]Related articles

    15.

    Evidence for cooperativity in the rejection of cardiac grafts mediated by CD4 TCR Tg T cells specific for a defined allopeptide.

    Honjo K, Yan Xu X, Kapp JA, Bucy RP.

    Am J Transplant. 2004 Nov;4(11):1762-8.PMID: 15476474 [PubMed - indexed for MEDLINE]Related articles

    16.

    CD4+ T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition.

    Honjo K, Xu X, Bucy RP.

    Transplantation. 2004 Feb 15;77(3):452-5.PMID: 14966425 [PubMed - indexed for MEDLINE]Related articles

    17.

    Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.

    Bartlett JA, Miralles GD, Sevin AD, Silberman M, Pruitt SK, Ottinger J, Gryszowska V, Fiscus SA, Bucy RP; ACTG 380 Study Team.

    AIDS Res Hum Retroviruses. 2002 May 20;18(8):535-43.PMID: 12036483 [PubMed - indexed for MEDLINE]Related articles

    18.

    Immune function in patients with rheumatoid arthritis treated with etanercept.

    Moreland LW, Bucy RP, Weinblatt ME, Mohler KM, Spencer-Green GT, Chatham WW.

    Clin Immunol. 2002 Apr;103(1):13-21.PMID: 11987981 [PubMed - indexed for MEDLINE]Related articles

    19.

    Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway.

    Stephensen CB, Rasooly R, Jiang X, Ceddia MA, Weaver CT, Chandraratna RA, Bucy RP.

    J Immunol. 2002 May 1;168(9):4495-503.PMID: 11970994 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.

    Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP.

    AIDS Res Hum Retroviruses. 2002 Jan 20;18(2):95-102.PMID: 11839142 [PubMed - indexed for MEDLINE]Related articles

    21.

    Perspectives on inducing efficient immune control of HIV-1 replication--a new goal for HIV therapeutics?

    Bucy RP, Kilby JM.

    AIDS. 2001 Feb;15 Suppl 2:S36-42. Review.PMID: 11424975 [PubMed - indexed for MEDLINE]Related articles

    22.

    Viral and Cellular Dynamics in HIV Disease.

    Bucy RP.

    Curr Infect Dis Rep. 2001 Jun;3(3):295-301.PMID: 11384561 [PubMed - as supplied by publisher]Related articles

    23.

    Quantitation of HIV-1 by real-time PCR with a unique fluorogenic probe.

    Saha BK, Tian B, Bucy RP.

    J Virol Methods. 2001 Apr;93(1-2):33-42.PMID: 11311341 [PubMed - indexed for MEDLINE]Related articles

    24.

    Heterogeneity of T cell clones specific for a single indirect alloantigenic epitope (I-Ab/H-2Kd54-68) that mediate transplant rejection.

    Honjo K, Xu XY, Bucy RP.

    Transplantation. 2000 Nov 27;70(10):1516-24.PMID: 11118099 [PubMed - indexed for MEDLINE]Related articles

    25.

    Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.

    Kilby JM, Goepfert PA, Miller AP, Gnann JW Jr, Sillers M, Saag MS, Bucy RP.

    Ann Intern Med. 2000 Sep 19;133(6):435-8. Review.PMID: 10975961 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Stability in the HIV vDNA pool in peripheral CD4+ T cells of untreated patients by single tube quantitative PCR.

    Hockett RD Jr, Saag MS, Kilby JM, Sfakianos G, Wakefield TB, Bucy RP.

    J Virol Methods. 2000 Jun;87(1-2):1-12.PMID: 10856747 [PubMed - indexed for MEDLINE]Related articles

    27.

    Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infection.

    Markert ML, Hicks CB, Bartlett JA, Harmon JL, Hale LP, Greenberg ML, Ferrari G, Ottinger J, Boeck A, Kloster AL, McLaughlin TM, Bleich KB, Ungerleider RM, Lyerly HK, Wilkinson WE, Rousseau FS, Heath-Chiozzi ME, Leonard JM, Haase AT, Shaw GM, Bucy RP, Douek DC, Koup RA, Haynes BF, Bolognesi DP, Weinhold KJ.

    AIDS Res Hum Retroviruses. 2000 Mar 20;16(5):403-13.PMID: 10772526 [PubMed - indexed for MEDLINE]Related articles

    28.

    Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy.

    Sharkey ME, Teo I, Greenough T, Sharova N, Luzuriaga K, Sullivan JL, Bucy RP, Kostrikis LG, Haase A, Veryard C, Davaro RE, Cheeseman SH, Daly JS, Bova C, Ellison RT 3rd, Mady B, Lai KK, Moyle G, Nelson M, Gazzard B, Shaunak S, Stevenson M.

    Nat Med. 2000 Jan;6(1):76-81.PMID: 10613828 [PubMed - indexed for MEDLINE]Related articles

    29.

    The Arthus reaction in rodents: species-specific requirement of complement.

    Szalai AJ, Digerness SB, Agrawal A, Kearney JF, Bucy RP, Niwas S, Kilpatrick JM, Babu YS, Volanakis JE.

    J Immunol. 2000 Jan 1;164(1):463-8.PMID: 10605043 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.

    Derdeyn CA, Kilby JM, Miralles GD, Li LF, Sfakianos G, Saag MS, Hockett RD, Bucy RP.

    J Infect Dis. 1999 Dec;180(6):1851-62.PMID: 10558941 [PubMed - indexed for MEDLINE]Related articles

    31.

    Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.

    Kasono K, Blackwell JL, Douglas JT, Dmitriev I, Strong TV, Reynolds P, Kropf DA, Carroll WR, Peters GE, Bucy RP, Curiel DT, Krasnykh V.

    Clin Cancer Res. 1999 Sep;5(9):2571-9.PMID: 10499635 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Correlation between circulating stromal cell-derived factor 1 levels and CD4+ cell count in human immunodeficiency virus type 1-infected individuals.

    Derdeyn CA, Costello C, Kilby JM, Sfakianos G, Saag MS, Kaslow R, Bucy RP.

    AIDS Res Hum Retroviruses. 1999 Aug 10;15(12):1063-71.PMID: 10461826 [PubMed - indexed for MEDLINE]Related articles

    33.

    The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin.

    Louro ID, McKie-Bell P, Gosnell H, Brindley BC, Bucy RP, Ruppert JM.

    Cell Growth Differ. 1999 Jul;10(7):503-16.PMID: 10437918 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA.

    Hockett RD, Kilby JM, Derdeyn CA, Saag MS, Sillers M, Squires K, Chiz S, Nowak MA, Shaw GM, Bucy RP.

    J Exp Med. 1999 May 17;189(10):1545-54.PMID: 10330433 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

    Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M, Mitsuyasu RT, Kilby JM.

    J Clin Invest. 1999 May 15;103(10):1391-8.PMID: 10330421 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection.

    Bucy RP.

    AIDS Res Hum Retroviruses. 1999 Feb 10;15(3):223-7. No abstract available. PMID: 10052752 [PubMed - indexed for MEDLINE]Related articles

    37.

    Heterogeneity in the clonal T cell response. Implications for models of T cell activation and cytokine phenotype development.

    Weaver CT, Saparov A, Kraus LA, Rogers WO, Hockett RD, Bucy RP.

    Immunol Res. 1998;17(3):279-302. Review.PMID: 9638473 [PubMed - indexed for MEDLINE]Related articles

    38.

    Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis.

    Roberts FA, Hockett RD Jr, Bucy RP, Michalek SM.

    Oral Microbiol Immunol. 1997 Dec;12(6):336-44.PMID: 9573807 [PubMed - indexed for MEDLINE]Related articles

    39.

    Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis.

    Moreland LW, Haverty TP, Wacholtz MC, Knowles RW, Bucy RP, Heck LW Jr, Koopman WJ.

    J Rheumatol. 1998 Feb;25(2):221-8.PMID: 9489810 [PubMed - indexed for MEDLINE]Related articles

    40.

    Effects of tapering doses of oral prednisone on viral load among HIV-infected patients with unexplained weight loss.

    Kilby JM, Tabereaux PB, Mulanovich V, Shaw GM, Bucy RP, Saag MS.

    AIDS Res Hum Retroviruses. 1997 Nov 20;13(17):1533-7.PMID: 9390753 [PubMed - indexed for MEDLINE]Related articles

    41.

    The effect of rhGH in vitro on donor-specific hyporesponsiveness in pediatric transplantation.

    Benfield MR, Vail A, Waldo FB, Bucy RP, Kohaut EC.

    Pediatr Transplant. 1997 Aug;1(1):90-7.PMID: 10084793 [PubMed - indexed for MEDLINE]Related articles

    42.

    Single-cell analyses of CD4+ T cells from alpha beta T cell receptor-transgenic mice: a distinct mucosal cytokine phenotype in the absence of transgene-specific antigen.

    Saparov A, Elson CO, Devore-Carter D, Bucy RP, Weaver CT.

    Eur J Immunol. 1997 Jul;27(7):1774-81.PMID: 9247591 [PubMed - indexed for MEDLINE]Related articles

    43.

    Immunosuppression by inhibition of cellular adhesion mediated by leukocyte function-associated antigen-1/intercellular adhesion molecule-1 in murine cardiac transplantation.

    Xu XY, Honjo K, Devore-Carter D, Bucy RP.

    Transplantation. 1997 Mar 27;63(6):876-85.PMID: 9089229 [PubMed - indexed for MEDLINE]Related articles

    44.

    Transductional efficacy and safety of an intraperitoneally delivered adenovirus encoding an anti-erbB-2 intracellular single-chain antibody for ovarian cancer gene therapy.

    Deshane J, Siegal GP, Wang M, Wright M, Bucy RP, Alvarez RD, Curiel DT.

    Gynecol Oncol. 1997 Mar;64(3):378-85.PMID: 9062138 [PubMed - indexed for MEDLINE]Related articles

    45.

    Visualization of antigen-specific T cell activation and cytokine expression in vivo.

    Rogers WO, Weaver CT, Kraus LA, Li J, Li L, Bucy RP.

    J Immunol. 1997 Jan 15;158(2):649-57.PMID: 8992980 [PubMed - indexed for MEDLINE]Related articles

    46.

    Growth hormone induces interferon gamma production and may play a role in the presentation of alloantigens in vitro.

    Benfield MR, Vail A, Bucy RP, Weigent DA.

    Neuroimmunomodulation. 1997 Jan-Feb;4(1):19-27.PMID: 9326741 [PubMed - indexed for MEDLINE]Related articles

    47.

    The effect of recombinant human growth hormone on responses to alloantigens in the pediatric transplant patient.

    Benfield MR, Vail A, Waldo FB, Bucy RP, Kohaut EC.

    Pediatr Nephrol. 1996 Jun;10(3):280-2.PMID: 8792390 [PubMed - indexed for MEDLINE]Related articles

    48.

    Gamma delta T cells are secondary participants in acute graft-versus-host reactions initiated by CD4+ alpha beta T cells.

    Tsuji S, Char D, Bucy RP, Simonsen M, Chen CH, Cooper MD.

    Eur J Immunol. 1996 Feb;26(2):420-7.PMID: 8617313 [PubMed - indexed for MEDLINE]Related articles

    49.

    Simultaneous quantitation of multiple cytokine mRNAs by RT-PCR utilizing plate based EIA methodology.

    Hockett RD Jr, Janowski KM, Bucy RP.

    J Immunol Methods. 1995 Dec 1;187(2):273-85.PMID: 7499887 [PubMed - indexed for MEDLINE]Related articles

    50.

    Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.

    Saleh MN, Khazaeli MB, Wheeler RH, Bucy RP, Liu T, Everson MP, Munn DH, Schlom J, LoBuglio AF.

    Cancer Res. 1995 Oct 1;55(19):4339-46.PMID: 7671245 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...